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Abstract
Primary glaucoma is one of the most common causes of irreversible blindness both in humans and in dogs. Glaucoma is an
optic neuropathy affecting the retinal ganglion cells and optic nerve, and elevated intraocular pressure is commonly
associated with the disease. Glaucoma is broadly classified into primary open angle (POAG), primary closed angle (PCAG)
and primary congenital glaucoma (PCG). Human glaucomas are genetically heterogeneous and multiple loci have been
identified. Glaucoma affects several dog breeds but only three loci and one gene have been implicated so far. We have
investigated the genetics of primary glaucoma in the Norwegian Elkhound (NE). We established a small pedigree around the
affected NEs collected from Finland, US and UK and performed a genome-wide association study with 9 cases and 8 controls
to map the glaucoma gene to 750 kb region on canine chromosome 20 (praw = 4.93610
26, pgenome = 0.025). The associated
region contains a previously identified glaucoma gene, ADAMTS10, which was subjected to mutation screening in the
coding regions. A fully segregating missense mutation (p.A387T) in exon 9 was found in 14 cases and 572 unaffected NEs
(pFisher = 3.5610
227) with a high carrier frequency (25.3%). The mutation interrupts a highly conserved residue in the
metalloprotease domain of ADAMTS10, likely affecting its functional capacity. Our study identifies the genetic cause of
primary glaucoma in NEs and enables the development of a genetic test for breeding purposes. This study establishes also a
new spontaneous canine model for glaucoma research to study the ADAMTS10 biology in optical neuropathy.
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Introduction
Glaucoma is an optic neuropathy affecting the retinal ganglion
cells and optic nerve. Elevated intraocular pressure (IOP) is
commonly associated with the disease. However, normal tension
glaucoma is diagnosed as well [1]. Human glaucomas form a
heterogeneous group of diseases, which are broadly classified into
primary open-angle (POAG), primary closed-angle (PCAG) and
primary congenital glaucoma (PCG) [2]. POAG is the most
common form in humans [2]. In POAG, the iridocorneal angle
(ICA) is open with an elevated IOP, which is considered as a
significant risk factor for the disease. PCAG results from the
collapse of the ICA structures, elevated IOP and subsequent death
of the retinal cells [3]. Elevated IOP is caused by the blockage of
the aqueous humor outflow due to a shallow anterior chamber
combined with the obstruction of the iris-trabecular meshwork in
the iridocorneal angle of the eye, [4]. PCG occurs within the first
few years of life and is characterized by abnormalities in the
anterior chamber angle and elevated IOP [4].
In human, several loci [5–6] and several genes including,
contactin 4 (CNTN4) [7], myocilin (MYOC) [8], neurotrohin 4
(NTF4) [9], optineurin (OPTN) [10] and WD repeat domain 36
(WDR36) [11] have been associated with POAG. Three loci [6]
and the two genes cytochrome P450 1B1 (CYP1B1) [12] and
latent transforming growth factor beta binding protein 2 (LTBP2)
[13] have been associated with PCG. Three loci have been
associated with PCAG, in which separate markers showed
significant association after replication on human chromosomes
1, 8 and 11 [14]. Only one causative gene ATP-binding cassette,
sub-family C (CFTR/MRP), member 5 (ABCC5) has been
associated with PCAG [15]. Furthermore, multiple genes and loci
have been associated with syndromes and other ocular conditions
accompanied by glaucoma [6]. However, glaucoma is considered
a multifactorial disease and although several variants have been
identified for familial cases, the glaucoma genetics remains
controversial [16–17].
In dogs, POAG and PCAG have been described in several
breeds [18]. Clinical features resemble human glaucoma, includ-
ing loss of the retinal ganglion cells and elevated IOP.
Abnormalities in the pectinate ligament (PL) structure are
considered as a risk factor in canine PCAG [19–24]. The
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pectinate ligament forms the internal boundary of the canine ICA
and is presented as pillar of tissue. It project from the base of iris to
the peripheral Descemet’s membrane. It provides support for the
iris to the posterior cornea [25]. Although structural abnormalities
are considered a risk for the disease, not all dogs affected with PLD
develop glaucoma, suggesting other genetic risk factors.
Despite the presence of glaucoma in many breeds the genetic
etiology of glaucoma is almost completely unknown in dogs. A
novel locus was mapped in Dandie Dinmont Terriers [19] and two
loci were suggested for the Basset Hound [26] with PCAG. In a
research colony of Beagles a recessive mutation (p.G661R) in the
ADAM metallopeptidase with thrombospondin type 1 motif, 10
(ADAMTS10), has been found in a research colony of Beagles
with POAG has been suggested as causative [27]. The early
clinical signs in the affected Beagles include open ICA that
narrows as the disease progresses, gradual increase in IOP that
eventually leads to retinal ganglion cell death, optic nerve atrophy,
and irreversible blindness [28]. The age of onset in Beagles varies
from 8 to 16 months [29].
In addition to Beagles, Norwegian Elkhounds are also affected
with POAG [30–31]. Unlike the Beagle, the disease in NEs is
commonly diagnosed in middle-aged or elderly dogs when it starts
to affect the dogs hunting capabilities [30]. However, the actual
disease onset may be much earlier. Early clinical signs in NEs
include a slightly elevated IOP with a normal opening of the ciliary
cleft [30]. The peripheral vision is commonly affected. At the later
stages of the disease, the narrowing of the ciliary cleft contributes
to the elevation of IOP. This may lead to secondary subluxation of
the lenses in some cases. The vision deterioration continues to
expand due to optic nerve atrophy and cupping. The retina
appears funduscopically normal until the late stages of the disease.
Other clinical signs include Haabs striae, cataract, and buphthal-
mos [30].
We aimed to find the genetic cause of primary glaucoma in NEs
in this study to better understand the molecular pathogenesis, to
establish a large, spontaneous canine model for POAG research,
and to develop a genetic test for breeding purposes. We discovered
a novel missense mutation in the ADAMTS10 gene.
Materials and Methods
Study cohort
Blood samples from 596 NEs, including 16 glaucoma affected
dogs from Finland, Norway, Sweden, United Kingdom and
United States were collected to the canine DNA bank at the
University of Helsinki, Finland with owners consent and under the
permission of the Animal Ethical Committee of County Admin-
istrative Board of Southern Finland (ESAVI/6054/04.10.03/
2012). All affected dogs were examined by a certified veterinary
ophthalmologist. The clinical diagnoses indicated bilateral primary
glaucoma with significantly elevated IOP, between 25–86 mmHg
(normal 10–20 mmHg), and no detectable underlying cause. In
addition, various degrees of optic nerve atrophy and cupping were
reported. In addition, a progressive vision loss was detected in the
affected dogs leading to complete blindness. Other, secondary
clinical signs included lens luxation, corneal stromal edema, Haabs
striae, keratitis, vitreal syneresis and retinal degeneration. The
average age at the time of diagnosis was 6.5 years.
Genomic DNA was extracted from EDTA blood using
Chemagic Magnetic Separation Module I (MSM I) (Chemagen
Biopolymer-Technologie AG, Baeswieler, Germany) according to
the manufacturer’s instructions. DNA from buccal swabs (Euro-
tubo Cytobrush, sterile, 200 mm, Danlab, Helsinki, Finland) was
extracted using QIAamp DNA Mini Kit (Qiagen).
Genome wide association study
A genome-wide association study (GWAS) was performed using
Illumina’s CanineHD BeadChip array (San Diego, CA, USA) with
9 cases and 8 controls (Fig. 1). The control dogs were at least 8
years of age without any clinical signs of glaucoma. Genotyping
was performed at the Geneseek (Lincoln, NE, USA) and the
genotyping data was analyzed using PLINK 1.07 analysis
software. A total of 173,662 markers were initially included for
the analysis. No individual were removed for low genotyping
success of 95%. Missingness test of 95% removed 17,484 SNPs. A
total of 72,715 SNPs had minor allele frequency of less than 5%
and were removed. None of the SNPs deviated from Hardy-
Weinberg equilibrium based of HWE test of P,=0.0001. After
frequency and genotyping pruning, 89,277 SNPs remained in the
analysis. A case-controls association test was performed using
PLINK software to compare the allele frequencies between cases
and controls (Fig. 2A). Identity-by-state (IBS) clustering and
CMH meta-analysis (PLINK) were used to adjust for population
stratification. Genome-wide corrected empirical p-values were
determined applying 100,000 permutations to the data. Besides
PLINK the data was analyzed with compressed mixed linear
model [32] implemented in the GAPIT R package [33] and with
R-implemented GenABEL [34] software (data not shown). The
GWAS data is publicly available at dbSNP database (http://www.
ncbi.nlm.nih.gov/projects/SNP/).
Candidate gene sequencing
The coding regions of the best candidate gene in the associated
region, ADAMTS10, were first sequenced in four NE cases, in
four NE controls (unaffected .8 years) and in one unaffected
Rough Collie samples. The identified candidate mutation was then
validated in 596 NEs, including 7 additional cases. In addition, the
mutation was studied in 71 dogs from 17 other breeds affected
with POAG, PCAG or PLD and in 115 unaffected dogs from 6
breeds (Table S1).
Primer pairs (Table S2) were designed for the ADAMTS10
gene to amplify the coding regions and splice sites by standard
PCR (Table S2). PCRs were carried out in 12 ml reactions
consisting of 1.2 U Biotools DNA Polymerase (Biotools, Madrid,
Spain), 1.5 mM MgCl2 (Biotools, Madrid, Spain), 200 mM dNTPs
(Finnzymes, Espoo, Finland), 1 x Biotools PCR buffer without
MgCl2 (Biotools, Madrid, Spain), 0.83 mM forward and reverse
primer (Sigma Aldrich, St. Louis, USA) and 10 ng template
genomic DNA. Reaction mixtures were subjected to a thermal
cycling program of 95uC for 10 min, followed by 35 cycles of 95uC
for 30 s, 30 s at the annealing temperature and 72uC for 60 s and
a final elongation stage of 72uC for 10 min. ExoSap purified PCR
fragments were Sanger sequenced in our core facility the FIMM
Technology Center using ABI 3730xl DNA analyzer (Applied
Biosystems, Foster City, California, USA). Sequence data analysis
was performed using the Sequencher software (Gene Codes, Ann
Arbor, MI, USA). Build 3.1 of the canine genome reference
sequence was applied in the study.
Results
We established a global sample cohort including glaucoma
affected (n= 16) and unaffected NEs (.570) to map the disease
locus, to identify the causative gene and to validate the segregation
of the mutation. We performed a GWAS in a small pedigree of 9
cases and 8 controls. Statistical analyses revealed a 750 kb locus on
CFA20 with 23 most highly associated SNPs between
53070684 bp to 53816416 bp (praw = 4.93610
206, pgenome =
0.025) (Fig. 2B, C). A mild population stratification was identified
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in the study cohort by genome wide IBS clustering (genomic
inflation factor l=1.1) (Fig. S2), but it did not affect the result as
two mixed model approaches (GenABEL and GAPIT) that better
control for population stratification, gave the same results (data not
shown).
A pedigree constructed around the affected dogs using GenoPro
genealogy software (http://www.genopro.com) suggested a reces-
sive mode of inheritance as the affected dogs are born to
unaffected parents and there are multiple affected littermates in
some litters.
The identified locus contains 35 genes including a known canine
POAG gene, ADAMTS10 (Fig. 2D). It was selected for mutation
screening in the coding regions and splice sites in four affected and
five control dogs. Sequencing identified altogether ten variants; a
non-synonymous variant c.1441G.A, p.A387T in the exon 9
(Fig. 3A, B), five synonymous and four non-coding variants
(Table S3). Only one out of the five synonymous variants,
p.P171P, co-segregated with the non-synonymous variant. How-
ever, it was not suspected to be in the exonic enhancer region
when analyzed by the ESE-finder [35]. Instead, the non-
synonymous variant was predicted to be pathogenic based on
the bioinformatics prediction tools Polyphen2 [36] and SIFT [37].
The mutation affects a highly conserved residue (present in 75
species, Fig. S1) in the metalloprotease domain of ADAMTS10
protein (Fig. 3C).
To gather further evidence for the p.A387T segregation, we
genotyped seven additional NE primary glaucoma cases and four
obligatory carriers (Fig. 1) and 572 randomly selected unaffected
NEs. All but two of the cases were homozygous for the mutation.
Unfortunately, we have a limited access to the health records and
history of these two affected dogs and they may have had a
secondary glaucoma with a primary underlying cause such as
inflammation being missed at the end stage of disease when the
animals were presented to the veterinary ophthalmologist. All four
obligatory carriers were heterozygous. Genotyping of the 572 NEs
indicated a 25.3% carrier frequency (151/596) and revealed one
additional homozygous dog. This genetically affected dog is now 5
years old without signs of glaucoma yet but needs to be followed
up since the average age of diagnosis in the breed is at 6.5 years of
age. Collectively, these results support a segregation of a mutation
in clinically confirmed primary glaucoma cases with a highly
significant association between the mutation and disease when
comparing genotyped genetically affected dogs (n = 16) and
unaffected using Fisher’s exact test (PFisher = 3.5610
227). The
breed-specificity of the p.A387T mutation was indicated by
excluding it from 71 glaucoma or PLD affected dogs from 17
breeds and from 115 unaffected dogs from six breeds.
Discussion
Our study has identified a novel recessive mutation in the
ADAMT10 gene in the NEs affected with primary glaucoma using
genome wide association analysis and candidate sequencing
strategies. We mapped the disease to a known canine POAG
locus including the ADAMTS10 candidate gene and subsequently
identified a missense mutation in the exon 9 of the ADAMTS10
gene. This is consistent with the previously reported POAG
phenotype of primary glaucoma in this breed [30–31]. The
recessively segregating mutation results in an alanine to threonine
change (p.A387T) in a highly conserved functional metallopro-
tease domain of the protein (Fig. 3C), which likely impairs
ADAMTS10 function, leading to POAG in the homozygous dogs.
ADAMTS10 is a secreted glycoprotein [38] and belongs to a
family of metalloproteinases that contribute to the dynamics of the
extracellular matrix (ECM) composition and microfibril function
[38–40]. It may have a role in the storage and activation of latent
transforming growth factor beta (TGFb), which regulates the
collagen turnover [41–43] as well as in the remodeling of the
mesenchymal and basement membranes [44].
The members of the ADAMTS family share the same structural
organization including catalytic metalloprotease domain, followed
by a disintegrin-like, and cysteine-rich domains, a thrombospondin
repeat and a spacer region (Fig. 3C). ADAMTS10 differs from
the others having five thrombospondin type 1 repeats and a PLAC
domain in the C-terminal [44].
ADAMTS10 interacts with fibrillin-1 and localized to fibrillin-1
microfibril bundles [39]. It maintains the lens in its position via
lens ligaments, which are comprised primarily from fibrillin-1 [43].
Microfibrils localize and activate TGFb [45]. Fibrillin-1 is
expressed in the outflow pathway of the aqueous humor and
Figure 1. Pedigree of glaucoma affected Norwegian Elkhounds. The pedigree constructed around affected dogs indicates a likely recessive
mode of inheritance as the affected dogs are born to unaffected parents and there are multiple affected littermates in some litter. The squared dogs
were included in the GWAS. Individuals marked with yellow background were genotyped as obligatory carriers and were all heterozygous for the
mutation.
doi:10.1371/journal.pone.0111941.g001
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Figure 2. Genome wide association study. A) A Manhattan plot of genome-wide case-control association analysis with 8 cases and 9 controls
indicate the most highly associated region in CFA20. B) The glaucoma associated region on chromosome 20 spans from 53.1 Mb to 53.8 Mb. C)
Genotypes at the associated region on CFA20. All cases share a 750 kb homozygous block. D) The associated region harbors 35 genes of which only
ADAMTS10 has been associated with POAG.
doi:10.1371/journal.pone.0111941.g002
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defect in the fibrillin-1 may lead to impaired aqueous humor flow
[46–48].
In dogs, a missense mutation (p.G661R) in the ADAMTS10
gene has been previously associated with POAG in a research
colony of Beagles. The Beagle mutation is positioned in the
cysteine rich domain and is hypothesized to disrupt protein folding
leading to instability [27].
The NE mutation is different from the Beagles and may result in
a different pathogenesis. NE mutation changes a highly conserved
residue in the metalloprotease domain, which plays a role in the
remodeling of the connective tissue (Fig. 3C) [44]. Human
metalloprotease domain mutations have revealed abnormalities
in the cellular cytoskeleton [44], suggesting abnormal interactions
with the ECM. These abnormalities may eventually result in
defective microfibrils and glaucoma through alterations in
biomechanical properties of tissue and/or through effects on
signaling through TGFb, which is known to be elevated in the
aqueous humor of glaucoma patients [49]. Unfortunately, we did
not have access to any tissue samples from the affected dogs to
further investigate the functional consequences of the mutation for
ADAMTS10 and its pathway. Secondary lens luxation diagnosed
in the affected NEs may be due to abnormal fibrillin-1 functions as
the ADAMTS10 and fibrillin-1 interaction may be impaired
causing disruption of the lens ligaments.
Dagoneau et al. identified three causative mutations in the
metalloprotease domain of ADAMTS10 in human WMS patients
[44]. When studying patient fibroblasts they noted that abnor-
mally large bundles of actin were present, which were reflection of
Figure 3. A missense mutation in the ADAMTS10. A) A schematic representation of the ADAMTS10 gene structure. The gene is composed of 24
coding exons (dark blue) and the c.1441G.A variant is positioned in the exon 9 (not in scale). B) Chromatograms of the non-synonymous variant
position in an affected, a carrier and a wild-type dog. C) The p.A387T variant is positioned in the catalytic metalloprotease domain.
doi:10.1371/journal.pone.0111941.g003
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cytoskeleton abnormalities as a result of impaired connections
between cytoskeleton and ECM [44].
Mutations in ADAMTS10 [44], [50], ADAMTS17 [50] and in
fibrillin 1 (FBN1) [51] have been associated with a Weill-
Marchesani syndrome (WMS) (OMIM 277600). WMS is a
connective tissue disorder and characterized by several eye defects
including glaucoma, myopia, ectopia lentis, microspherophakia
and other features such as short stature, brachydactyly, joint
stiffness in the hands, restricted articular movements and some
facial features [52]. Glaucoma is diagnosed in WMS patients, but
ectopia lentis is the more prevalent clinical sign [53]. In WMS
patients the ectopia lentis and dysgenesis of the lens ligament is
suspected to be caused by abnormal biogenesis of fibrillin-1 [39].
The same is likely true for ADAMTS17-mutant dogs [54] and
ADAMTS10-mutant Beagles [27]. Interestingly, none of our
affected NE dogs presented with signs of primary lens luxation,
although this should be expected. Histologic analyses of the lens
zonules would be very helpful to identify possible signs of zonular
dysplasia. Another difference in the affected NE dogs relates to the
lack of severe non-ocular signs, which are commonly present in the
WMS patients with mutation in the ADAMTS10 and
ADAMTS17 genes. Further studies are warranted to investigate
whether the observed breed- and species–specific differences are
due to alternate mutations in the metalloproteinase domains or
possible other factors.
In summary, we have discovered the genetic cause of primary
glaucoma in the NEs by identifying a missense mutation in
ADAMTS10. This study implicates the significant role of
ADAMTS10 in canine POAG by identifying the second mutation
in the same gene in dogs. Our affected dogs establish a new model
to study ADAMTS10 biology in the microfibrillin theory of the
glaucoma [49]. Importantly, given the high frequency of the
mutation in the NE breed, our study is a breakthrough for the NE
breeders, who will benefit from the genetic test to reduce the
disease frequency in future populations.
Supporting Information
Figure S1 ADAMTS10 protein alignments. ADAMTS10
sequence alignment between different species. The mutation is
located in a highly conserved region across 75 species. The arrow
marks the mutated alanine residue.
(ZIP)
Figure S2 Q-Q plots. Identity-by-state (IBS) clustering and
CMH meta-analysis (PLINK) were used to adjust for population
stratification (A). A mild population stratification was identified in
the study cohort by genome wide IBS clustering (adjusted genomic
inflation factor l=1.1) (B).
(TIF)
Table S1 Dogs affected with glaucoma of PLD (71 dogs
in 17 breeds) and healthy dog (115 dogs in six breeds)
were sequenced for the ADAMTS10 mutation.
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Table S2 Primers used for PCR amplification and
sequencing of canine ADAMTS10 coding regions.
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Table S3 A total of 10 variants were in the coding and
splice site regions of ADAMTS10.
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